Docetaxel, Cisplatin, and 5‐Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma-Reference-Cited by-同舟云学术

Docetaxel, Cisplatin, and 5‐Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma

Published:2016-10-11 Issue:11 Volume:5 Page:3085-3093
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Fiteni Frédéric¹²,Paget‐Bailly Sophie²,Messager Mathieu³⁴,N'Guyen Thierry¹,Lakkis Zaher⁵,Mathieu Pierre⁵,Lamfichekh Najib⁶,Picard Alain⁷,Benzidane Bilell⁸,Cléau Denis⁹,Bonnetain Franck²¹⁰,Borg Christophe¹¹¹¹²,Mariette Christophe³⁴,Kim Stefano¹¹¹¹²

Affiliation:

1. Department of Medical OncologyUniversity Hospital of Besançon Besançon France

2. Methodology and Quality of Life in Oncology UnitUniversity Hospital of Besançon Besançon France

3. Lille University HospitalDepartment of Digestive Surgery Lille France

4. FREGAT (French Esophageal and Gastric Tumour) working group Paris France

5. Department of Digestive Surgery and Liver TransplantationUniversity Hospital of Besançon Besançon France

6. Department of SurgeryNord Franche Comté Hospital Montbeliard France

7. Department of SurgeryNord Franche Comté Hospital Belfort France

8. Department of Oncology and RadiotherapyNord Franche Comté Hospital Montbeliard France

9. Department of GastroenterologyHospital of Vesoul Vesoul France

10. University of Franche‐Comté Besançon EA 3181 France

11. Unit 1098INSERMUniversity of Franche‐Comté Besançon France

12. Clinical Investigational CenterUniversity Hospital of Besançon CIC‐1431 France

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.885

Reference14 articles.

1. Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

2. Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

3. Neoadjuvant chemotherapy for advanced gastric cancer: A meta-analysis

4. Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group

5. Perioperative docetaxel, cisplatin, and 5-fluorouracil (DCF) for locally advanced esophageal and gastric adenocarcinoma: a multicenter phase II trial

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates in Translational Science for Esophageal and Gastric Cancers;Surgical Oncology Clinics of North America;2024-07

2. The Evolution of Neo-Adjuvant Therapy in the Treatment of Oesophageal and Gastro-Oesophageal Junction Adenocarcinomas;Cancers;2023-09-27

3. ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer;Nature Communications;2023-05-19

4. Efficacy and safety of FLOT regimen vs DCF, FOLFOX, and ECF regimens as perioperative chemotherapy treatments for resectable gastric cancer patients; a report from the middle east;Research in Pharmaceutical Sciences;2022

5. Long-Term Outcomes of Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer/Esophagogastric Junction Cancer: A Systematic Review and Meta-Analysis;Anti-Cancer Agents in Medicinal Chemistry;2022-01